Nebulized furosemide as a novel treatment for dyspnea in terminal cancer patients.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 11779672.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Three terminal cancer patients with severe dyspnea were treated with nebulized furosemide. The underlying causes of dyspnea varied. Twenty milligrams of furosemide was nebulized and inhaled four times each day. Dyspnea dramatically improved and could be controlled for weeks. No noticeable side effects were observed. Inhalation of nebulized furosemide seems to be an effective and useful treatment for dyspnea in terminal cancer patients, but these observations need to be confirmed in a randomized controlled trial.
Medical subject headings
- Diuretics
- Dyspnea
- Furosemide
- Nebulizers and Vaporizers
- Neoplasms
- Terminally Ill